Skip to content

All recalls FDA

FDADrugsRecalled Status: Completed

Esperion recalls NEXLIZET (bempedoic acid and ezetimibe) tablets

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
Products
  • NEXLIZET (bempedoic acid and ezetimibe) tablets
Company
Esperion
Where it was sold

Nationwide in the USA

Nationwide

Units affected
3,480 30-count bottles
About this recall
NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03